EGI
ANGO icon

EAM Global Investors’s AngioDynamics ANGO Stock Holding History

EAM Global Investors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-99,140
Closed -$2.69M – 193
2021
Q2 		$2.69M Buy
+99,140
New +$2.42M 0.74% 39
2018
Q3 		– Sell
-62,419
Closed -$1.39M – 152
2018
Q2 		$1.39M Buy
+62,419
New +$1.28M 0.68% 59

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EAM Global Investors's ANGO Position: Q3 2021 in Review

EAM Global Investors sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 99,140 shares — an estimated $2.69M sold.

EAM Global Investors first reported a position in ANGO in Q2 2018 and held it in 2 quarters. The position peaked at $2.69M in Q2 2021. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • EAM Global Investors reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • EAM Global Investors sold 99,140 AngioDynamics shares in Q3 2021, an estimated $2.69M.
  • EAM Global Investors first reported a position in AngioDynamics in Q2 2018 and held it in 2 quarters.
  • EAM Global Investors's AngioDynamics position peaked at $2.69M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.